Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review
By Adriano Marchese
Toronto-listed stocks started the week slightly lower midday Monday. On the macroeconomic side, manufacturing shipments in Canada rose 0.7% in February from the previous month to a seasonally adjusted 71.61 billion Canadian dollars ($51.98 billion), while wholesale trade was flat.
Sector performance was mixed in Canada, with gains mainly in distribution services, health services and commercial services offset by losses primarily in materials, energy and tech services.
Canada's S&P/TSX Composite Index at midday were trading 0.2% lower at 21867.81, and the blue-chip S&P/TSX 60 was down 0.1% at 1310.16.
Parkland's shares rose 4.9% to C$42.94 after the Canadian fuel retailer rejected a call from its largest shareholder to launch a strategic review of options, including a change in ownership.
Other market movers:
Canopy Growth shares fell by 5.6% to C$10.10 after it said it received shareholder approval to create and issue a new class of exchangeable shares as it looks to accelerate growth in the U.S. market.
Shares in Onex were 1.3% higher at C$97.91 after it said it plans to launch a share-repurchase program to buy back up to 10% of its issued and outstanding public shares over a one-year period.
Numinus Wellness shares fell 25% to C$0.08 after the mental health care company said it will consider divesting its Canadian clinical operations to focus on its U.S. business following a strategic review.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 15, 2024 12:18 ET (16:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks